KLA-Tencor Corporation (NASDAQ:KLAC) shares moved down -0.28% in last trading session and ended the day at $63.96. KLAC Gross Margin is 58.20% and its has a return on assets of 11.20%. KLA-Tencor Corporation (NASDAQ:KLAC) quarterly performance is -3.57%.
KLA-Tencor (NASDAQ: KLAC) declared a quarterly dividend of $0.52 per share, or $2.08 annualized. The dividend will be payable on March 1, 2016, to stockholders of record on February 16, 2016, with an ex-dividend date of February 11, 2016.
V.F. Corporation (NYSE:VFC) ended the last trading day at $56.66. Company weekly volatility is calculated as 3.27% and price to cash ratio as 42.63. V.F. Corporation (NYSE:VFC) showed a weekly performance of -9.13%.
VF Corporation (NYSE: VFC) plans to release its fourth quarter fiscal 2015 financial results on Friday, Feb. 19, 2016, at approximately 6:55 a.m. ET. Following the news release, VF management will host a conference call at approximately 8:30 a.m. ET to review results.
On 09 February, Commerce Bancshares, Inc. (NASDAQ:CBSH) shares advanced 0.22% and was closed at $41.09. CBSH EPS growth in last 5 year was 4.80%. Commerce Bancshares, Inc. (NASDAQ:CBSH) year to date (YTD) performance is -3.41%.
Commerce Bancshares (NASDAQ: CBSH) declared a quarterly dividend of $0.225 per share, or $0.9 annualized. The dividend will be payable on March 28, 2016, to stockholders of record on March 11, 2016, with an ex-dividend date of March 9, 2016.
Fate Therapeutics, Inc. (NASDAQ:FATE) shares advanced 6.51% in last trading session and ended the day at $1.80. FATE has a return on assets of -45.10%. Fate Therapeutics, Inc. (NASDAQ:FATE) quarterly performance is -62.50%.
Fate Therapeutics, Inc. (NASDAQ:FATE), presented a company overview at the Leerink Partners 5th Annual Global Healthcare Conference on Wednesday, February 10, 2016 at 1:25 p.m. ET in New York City.
BioLineRx, Ltd. (NASDAQ:BLRX) caters to the Healthcare space. Its weekly performance is -2.93%. On the last day of trading company shares ended up at $0.96.
BioLineRx (NASDAQ: BLRX), announced that its Chief Executive Officer, Kinneret Savitsky, Ph.D., and its Chief Financial and Operating Officer, Philip Serlin, presented a company update at the 2016 BIO CEO & Investor Conference on Monday, February 8, 2016 at 2:30 pm EST. The conference held at the Waldorf Astoria Hotel in New York.
Leave a Reply